HYM Investment Group CEO Thomas O’Brien makes his living tackling some of the most complex developments in Boston, transforming landmark properties into massive mixed-use projects like Roxbury’s P3, downtown’s Bulfinch Crossing and East Boston’s Suffolk Downs.
An advisory group backed plans for a major commercial development that would tap into Boston’s life science boom and create an estimated 2,700 jobs in one of the city’s poorest neighborhoods.
As city officials begin to review proposals for parcel P3, Boston-based HYM Investment Group wants to help Roxbury join the Greater Boston life science boom in force with 700,000 square feet of office and lab space.
